HIV prevention pill debated as FDA ruling nears
An advocacy group concerned about costs and possible health problems related to a drug being considered to help stop the spread of HIV infection to healthy people has asked U.S. regulators to delay or deny its approval. Los Angeles-based AIDS Healthcare Foundation has petitioned the Food and Drug Administration on the grounds studies have shown the pill, Truvada, is only partially effective in preventing transmission.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063